Introduction: We performed a pooled analysis of randomised clinical trials (RCT) on HPV vaccine efficacy in preventing cervical persistent infection. Methods: We carried out a bibliographic search on electronic databases and we selected RCT to perform the meta-analyses. Results: We selected five studies. The first meta-analysis, including all studies, showed an important reduction of the risk of infection from HPV 16 in vaccinated cohort [RR 0.10 (95% CI: 0.07-0.15)]. The second and third meta-analyses, including only studies on bivalent and tetravalent vaccines, showed a RR of 0.13 (95% CI: 0.09-0.20) for HPV 16 infections and a RR of 0.22 (95% CI: 0.13-0.38) for HPV 18 ones. Discussion: HPV vaccine efficacy in preventing persistent infection is high but there is the need for further studies on the duration of immunization and long-term vaccine efficacy. © 2007 Elsevier Ltd. All rights reserved.

HPV vaccine efficacy in preventing persistent cervical HPV infection: A systematic review and meta-analysis / LA TORRE, Giuseppe; C., De Waure; G., Chiaradia; A., Mannocci; W., Riccardi. - In: VACCINE. - ISSN 0264-410X. - 25:50(2007), pp. 8352-8358. [10.1016/j.vaccine.2007.09.027]

HPV vaccine efficacy in preventing persistent cervical HPV infection: A systematic review and meta-analysis

LA TORRE, Giuseppe;A. Mannocci;
2007

Abstract

Introduction: We performed a pooled analysis of randomised clinical trials (RCT) on HPV vaccine efficacy in preventing cervical persistent infection. Methods: We carried out a bibliographic search on electronic databases and we selected RCT to perform the meta-analyses. Results: We selected five studies. The first meta-analysis, including all studies, showed an important reduction of the risk of infection from HPV 16 in vaccinated cohort [RR 0.10 (95% CI: 0.07-0.15)]. The second and third meta-analyses, including only studies on bivalent and tetravalent vaccines, showed a RR of 0.13 (95% CI: 0.09-0.20) for HPV 16 infections and a RR of 0.22 (95% CI: 0.13-0.38) for HPV 18 ones. Discussion: HPV vaccine efficacy in preventing persistent infection is high but there is the need for further studies on the duration of immunization and long-term vaccine efficacy. © 2007 Elsevier Ltd. All rights reserved.
2007
efficacy; hpv vaccine; meta-analysis
01 Pubblicazione su rivista::01a Articolo in rivista
HPV vaccine efficacy in preventing persistent cervical HPV infection: A systematic review and meta-analysis / LA TORRE, Giuseppe; C., De Waure; G., Chiaradia; A., Mannocci; W., Riccardi. - In: VACCINE. - ISSN 0264-410X. - 25:50(2007), pp. 8352-8358. [10.1016/j.vaccine.2007.09.027]
File allegati a questo prodotto
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/363489
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? 15
  • Scopus 58
  • ???jsp.display-item.citation.isi??? 48
social impact